European Journal of Cancer
Volume 39, Issue 17 , Pages 2538-2547 , November 2003

Allelic imbalance at loci containing FGFR, FGF, c-Met and HGF candidate genes in non-small cell lung cancer sub-types, implication for progression

  • M. Beau-Faller

      Affiliations

    • Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-3-8812-7535; fax: +33-3-8812-7539
    • ,
  • M.P. Gaub

      Affiliations

    • Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • ,
  • A. Schneider

      Affiliations

    • Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • ,
  • E. Guérin

      Affiliations

    • Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • ,
  • Nicolas Meyer

      Affiliations

    • Département d'Information Médicale, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • ,
  • X. Ducrocq

      Affiliations

    • Service de Chirurgie Thoracique, Hôpital Civil, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • ,
  • G. Massard

      Affiliations

    • Service de Chirurgie Thoracique, Hôpital Civil, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • ,
  • B. Gasser

      Affiliations

    • Institut d'Anatomie Pathologique, Hôpital Civil, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • ,
  • R. Kessler

      Affiliations

    • Service de Pneumologie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • ,
  • E. Weitzenblum

      Affiliations

    • Service de Pneumologie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • ,
  • J.M. Wihlm

      Affiliations

    • Service de Chirurgie Thoracique, Hôpital Civil, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • ,
  • E. Quoix

      Affiliations

    • Service de Pneumologie Lyautey, Hôpital Civil, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
    • ,
  • P. Oudet

      Affiliations

    • Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France

Received 21 October 2002 ,Revised 2 January 2003 ,Accepted 26 March 2003.

References 

  1. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. In Sobin LH, ed. World Health Organization International Classification of Tumors. Histological Typing of Lung and Pleura. New York, Springer Verlag, 1999.
  2. Konata C, Ikeda N, Hiyoshi T, et al.  Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer. 1998;21:185–191
  3. Charloux A, Quoix E, Wolkowe N, Small D, Pauli G, Kreisman H. The increasing incidence of lung adenocarcinoma: reality or artefact, a review of the epidemiology of lung adenocarcinoma. Intern J Epidemiol. 1997;26:14–23
  4. Petersen S, Aninat-Meyer M, Schlüns K, Gellert K, Dietel M, Petersen I. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer. 2000;82:65–73
  5. Pei J, Balsara B, Li W, et al.  Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Gene Chromosome Cancer. 2001;31:282–287
  6. Goeze A, Schluns K, Wolf G, Thasler Z, Petersen S, Petersen I. Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol. 2002;196:8–16
  7. Virmani AK, Fong KW, Kodagoda D, et al.  Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosome Cancer. 1998;21:308–319
  8. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 1992;59:115–165
  9. Warbuton D, Schwarz M, Tefft D, Lores-Delgado G, Abderson KD, Cardoso WV. The molecular basis of lung morphogenesis. Mech. Dev. 2000;92:55–81
  10. Warbuton D, Tefft D, Mailleux A, et al.  Do lung remodeling, repair, and regeneration recapitulate respiratory ontogeny?. Am J Respir Crit Care Med. 2001;164:S59–S62
  11. Isakson BE, Luman RL, Seedorf GJ, Boitano S. Modulation of pulmonary alveolar type II cell phenotype and communication by extracellular matrix and KGF. Am J Physiol Cell Physiol. 2001;281:C1291–C1299
  12. Clark JC, Tichelaar JW, Wert SE, et al.  FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. Am J Physiol Lung Cell Mol Physiol. 2001;280:L705–L715
  13. Takanami I, Imamuma T, Hashizume Y, et al.  Expression of PDGF, IGF-II, bFGF and TGF-B1 in pulmonary adenocarcinoma. Path Res Pract. 1996;192:1113–1120
  14. Takanami I, Tanaka F, Hashizume T, et al.  The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers. Eur J Cancer. 1996;32A:1504–1509
  15. Takanami I, Tanaka F, Hashizume T, Kodaira S. Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblast growth factor, its receptor, and survival. Neoplasma. 1997;44:295–298
  16. Volm M, Koomägi R, Mattern J, Stammler G. Angiogenic growth factors and theirs receptors in non-small cell lung carcinomas and their relationship to drug response in vitro. Anticancer Res. 1997;17:99–104
  17. Volm M, Koomägi R, Mattern J, Stammler G. Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinoma. Eur J Cancer. 1997;33:691–693
  18. Guddo F, Fontanini G, Reina C, Vignola AM, Angeletti A, Bonsignore G. The expression of basic-fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression. Hum Pathol. 1999;30:788–794
  19. Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R. Role of hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 2002;13:41–59
  20. Tsao M-S, Liu N, Chen J-M, et al.  Differential expression of Met/hepatocyte growth factor receptor in sub-types of non-small cell lung cancers. Lung Cancer. 1998;20:1–16
  21. Karoui M, Hofmann-Radvanyi H, Zimmermann Ute, et al.  No evidence of somatic FGFR3 mutation in various types of carcinoma. Oncogene. 2001;20:5059–5061
  22. Mountain CF. Revision in the international system for staging lung cancer. Chest. 1997;111:1710–1717
  23. Schneider A, Borgnat S, Lang H, et al.  Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer. Cancer Res. 2000;60:4617–4622
  24. Cave-Riant F, Cuillerier B, Beau-Faller M, et al.  Association of genetic defects in primary resected lung adenocarcinoma revealed by targeted allelic imbalance analysis. Am J Respir Cell Mol Biol. 2002;27:495–502
  25. Berger W, Setinek U, Mohr T, et al.  Evidence of a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells. Int J Cancer. 1999;83:415–423
  26. Slodkowska J, Sikora J, Roszkowski-Sliz K, Radomyski A, Androsiuk W. Expression of vascular endothelial growth factor and basic fibroblast growth factor receptors in lung cancer. Analyt Quant Cytol Histol. 2000;22:398–402
  27. Mattern J, Koomägi R, Volm M. Biological characterization of sub-groups of squamous cell lung carcinoma. Clin. Cancer Res. 1999;5:1459–1463
  28. Lund EL, Thorsen C, Pedersen MWB, Junker N, Kristjansen PEG. Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro. Clin. Cancer Res. 2000;6:4287–4291
  29. Yiangou C, Gomm JJ, Coope RC, et al.  Fibroblast Growth Factor 2 in breast cancer: occurrence and prognostic significance. Br J Cancer. 1997;75:28–33
  30. To C, Seiden I, Liu N, Wigle D, Tsao M-S. High expression of Met/Hepatocyte Growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells. Exp. Cell Res. 2002;273:45–53
  31. Yi S, Chen JR, Viallet J, Schwall RH, Nakamura T, Schmidt EV. Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines. Br J Cancer. 1998;77:2162–2170

PII: S0959-8049(03)00623-3

doi: 10.1016/S0959-8049(03)00623-3

European Journal of Cancer
Volume 39, Issue 17 , Pages 2538-2547 , November 2003

Article Tools

* Image Usage & Resolution